Please Wait
Applying Filters...
Menu
Xls

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/the-world-first-liquid-formulation-of-recombinant-botulinum-toxin-type-a-has-obtained-ind-approval-by-the-fda-302258483.html

PR NEWSWIRE
25 Sep 2024
Evolus Introduces Nuceiva® In Australia
Evolus Introduces Nuceiva® In Australia

30 Jul 2024

// BUSINESSWIRE

https://www.businesswire.com/news/home/20240730657453/en

BUSINESSWIRE
30 Jul 2024

https://www.businesswire.com/news/home/20240619024966/en

BUSINESSWIRE
19 Jun 2024

https://www.businesswire.com/news/home/20240612853482/en

BUSINESSWIRE
12 Jun 2024

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125274

FDA
21 Sep 2023

https://www.koreabiomed.com/news/articleView.html?idxno=21928#:~:text=It%20is%20the%20first%20case,to%20improve%20the%20square%20jaw

KOREA BIOMED
28 Aug 2023